Three Xeris Biopharma insiders (C-suite/top officers) sold a total of ~$1.0M in stock over a 7-day window ending July 6, 2026, including a $723K sale by the CEO. The selling occurred near $8.03-$8.50, just off the stock's recent highs. While the dollar amount is modest relative to the $1.4B market cap (~0.07%), the cluster includes the CEO's largest single sale in the cluster and coincides with recent positive insider selling patterns (4 sales totaling $1.2M in the prior 30 days). No 10b5-1 pattern is evident from the data provided, and the cluster lacks an offsetting buy direction.
Price Chart
Executive Summary
Three Xeris Biopharma insiders (C-suite/top officers) sold a total of ~$1.0M in stock over a 7-day window ending July 6, 2026, including a $723K sale by the CEO. The selling occurred near $8.03-$8.50, just off the stock's recent highs. While the dollar amount is modest relative to the $1.4B market cap (~0.07%), the cluster includes the CEO's largest single sale in the cluster and coincides with recent positive insider selling patterns (4 sales totaling $1.2M in the prior 30 days). No 10b5-1 pattern is evident from the data provided, and the cluster lacks an offsetting buy direction.
Key Financial Metrics
Key Facts
- Three insiders sold a total of ~$1.0M in stock between June 29 and July 6, 2026
- CEO Kevin McCulloch sold 90,000 shares for ~$723K, the largest single trade in the cluster
- Hecht Beth (See Remarks) sold 16,700 shares at $8.03 for ~$134K
- Pieper Steven (See Remarks) sold 17,400 shares at $8.50 for ~$148K
- Total insider cluster value is ~$1.0M, or ~0.07% of the $1.4B market cap
- All three trades were open-market sales (code S); no buy transactions in the window
- Prior 30-day insider activity at XERS shows 4 additional sales totaling $1.2M
Financial Impact
Selling of ~$1.0M by three insiders, representing ~0.07% of market cap
Risk Factors
- Risk of a secondary offering if the company is capitalizing on the stock's recent strength
- CEOs selling a substantial portion of their holdings can signal limited upside confidence near current levels
- High proportion of bullish analyst consensus (85% Strong Buy/Buy) could amplify negative sentiment if selling is interpreted as insiders disagreeing with Street optimism
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-XERS-1783491272602 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | 8-K | $7.71 $7.78 | ▲ +0.91% | ▲ +1.56% | $9.08 (+17.77%) |
Sep 1, 2026 4w ago | Insider Cluster | $8.58 $7.67 | ▼ −10.61% | ▼ −9.65% | $9.08 (+5.83%) |
Aug 6, 2026 8w ago | 8-K | $7.36 $8.33 | ▲ +13.18% | ▲ +11.97% | $9.08 (+23.37%) |
Aug 4, 2026 8w ago | Insider Cluster | $8.19 $8.39 | ▲ +2.44% | ▲ +2.54% | $9.08 (+10.87%) |
Jul 7, 2026 12w ago | Insider Cluster | $8.94 $8.28 | ▲ +7.38% | ▲ +7.93% | $9.08 (−1.57%) |
Jul 2, 2026 13w ago | 3 | $8.28 $8.62 | ▲ +4.11% | ▲ +3.18% | $9.08 (+9.66%) |
Jul 2, 2026 13w ago | Insider Cluster | $8.28 $8.62 | ▲ +4.11% | ▲ +3.18% | $9.08 (+9.66%) |
Jun 30, 2026 13w ago | 8-K | $8.00 $8.94 | ▲ +11.75% | ▲ +11.49% | $9.08 (+13.50%) |
Jun 12, 2026 16w ago | Institutional Cluster | $6.79 $6.95 | ▲ +2.36% | ▲ +1.68% | $9.08 (+33.73%) |
Jun 5, 2026 16w ago | Insider Cluster | $6.24 $6.88 | ▲ +10.26% | ▲ +8.14% | $9.08 (+45.51%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access